Cencora, Inc.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

CEO

Robert P. Mauch

CEORobert P. Mauch

Employees

51,000

Employees51,000

Headquarters

Conshohocken, Pennsylvania

HeadquartersConshohocken, Pennsylvania

Founded

1947

Founded1947

Employees

51,000

Employees51,000

COR Key Statistics

Market cap

63.15B

Market cap63.15B

Price-Earnings ratio

25.16

Price-Earnings ratio25.16

Dividend yield

0.71%

Dividend yield0.71%

Average volume

1.23M

Average volume1.23M

High today

$338.07

High today$338.07

Low today

$330.31

Low today$330.31

Open price

$336.80

Open price$336.80

Volume

1.13M

Volume1.13M

52 Week high

$377.54

52 Week high$377.54

52 Week low

$244.82

52 Week low$244.82

Stock Snapshot

Cencora, Inc.(COR) stock is priced at $331.00, giving the company a market capitalization of 63.15B. It carries a P/E multiple of 25.16 and pays a dividend yield of 0.71%.

On 2026-10-23, Cencora, Inc.(COR) stock moved within a range of $330.31 to $338.07. With shares now at $331.00, the stock is trading +0.2% above its intraday low and -2.1% below the session's peak.

Trading volume for Cencora, Inc.(COR) stock has reached 1.13M, versus its average volume of 1.23M.

Over the past 52 weeks, Cencora, Inc.(COR) stock has traded between a high of $377.54 and a low of $244.82.

COR News

Simply Wall St 12h

American Oncology Network Looks Fully Priced Following Cencora’s $2.4b Bid

Cencora (COR) has agreed to buy the remaining 96% of American Oncology Network (OTCPK:AONC) it does not already own in a deal valuing AON at US$2.4b. American...

TipRanks 1d

Cencora price target raised to $345 from $330 at BofA

BofA raised the firm’s price target on Cencora (COR) to $345 from $330 and keeps a Neutral rating on the shares after the company announced an agreement to acqu...

Benzinga 2d

Here’s How Much You Would Have Made Owning Cencora Stock In The Last 5 Years - Benzinga

...

Analyst ratings

61%

of 18 ratings

Buy

61.1%

Hold

38.9%

Sell

More COR News

TipRanks 2d

Cencora to Acquire American Oncology Network in Expansion

An update from Cencora ( (COR) ) is now available. On October 21, 2026, Cencora announced a definitive agreement to acquire American Oncology Network, valuing...

Simply Wall St 6d

Will Raised EPS Guidance Change Cencora Stock Narrative

Cencora recently raised its fiscal 2026 EPS guidance, reflecting confidence in the earnings contribution from acquisitions such as OneOncology and the pharmaceu...

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.